Quick Answer
Quince Therapeutics, Inc. reported Shares Outstanding of 44.00 million shares for fiscal year 2024.
Quince Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 44.00M | +2.4% |
| 2023 | 42.97M | +18.9% |
| 2022 | 36.14M | +20.2% |
| 2021 | 30.07M | +1.8% |
| 2020 | 29.54M | +10.0% |
| 2019 | 26.87M | +687.4% |
| 2018 | 3.41M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 54.49M | +25.9% | +1.6% |
| June 30, 2025 | 53.62M | +23.9% | +21.6% |
| March 31, 2025 | 44.09M | +2.0% | +0.2% |
| December 31, 2024 | 44.00M | +2.4% | +1.7% |
| September 30, 2024 | 43.28M | +19.1% | +0.0% |
| June 30, 2024 | 43.28M | +19.1% | +0.1% |
| March 31, 2024 | 43.22M | +19.1% | +0.6% |
| December 31, 2023 | 42.97M | +18.9% | +18.2% |
- Quince Therapeutics, Inc. showed an increase of +2.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2024 period, Quince Therapeutics, Inc.’s shares outstanding has grown by 1189.5% (from 3.41 million shares to 44.00 million shares).
- The most recent figure is from Quince Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: